Academic Journals Database
Disseminating quality controlled scientific knowledge

Ticlopidine to prevent primary arteriovenous fistula failure in hemodialysis patients; a randomized controlled trial

ADD TO MY LIST
 
Author(s): Ghorbani Ali | Jasemi-Zergani Farzad

Journal: Journal of Renal Injury Prevention
ISSN 2345-2781

Volume: 2;
Issue: 3;
Start page: 109;
Date: 2013;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

Keywords: Arteriovenous fistula | Ticlopidine | Hemodialysis

ABSTRACT
Implication for health policy/practice/research/medical education:Primary arteriovenous fistula (AVF), failure remains a major problem for hemodialysis patients. Vascular access thrombosis prophylaxis needs to start early in the end-stage renal disease patient. Ticlopidine seems to be effective and safe for prevention of primary AVF failure in hemodialysis patients.
RPA Switzerland

RPA Switzerland

Robotic process automation

    

Tango Jona
Tangokurs Rapperswil-Jona